Form 4: Jaguar Health Director Acquires Convertible Note and Warrants

Director John Micek acquired a convertible promissory note and warrants for Jaguar Health common stock on March 31, 2025.

Summary

• On March 31, 2025, John Micek, a director of Jaguar Health, Inc., acquired a 6% convertible promissory note and a warrant to purchase common stock.
• The convertible note, priced at $5.555, allows Micek to convert into 9,000 shares of Jaguar Health's common stock.
• The note matures three months after issuance and was issued pursuant to a securities purchase agreement dated March 26, 2025.
• Micek also received a warrant to purchase up to 9,000 shares of common stock at an exercise price of $5.43 per share.
• The warrant is exercisable immediately and expires five years from issuance, upon a fundamental transaction, or a liquidation event.
• Following the transaction, Micek beneficially owns 9,000 shares underlying the convertible note and 9,000 shares underlying the warrant.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director's investment is generally a good sign, but the use of convertible notes and warrants also suggests the company may have limited access to traditional financing.

Positives

• The investment by a director signals confidence in the company's future.

Risks

• The conversion of the note and exercise of the warrants could dilute existing shareholders' equity.

Future Outlook

The document does not contain specific forward-looking statements beyond the terms of the convertible note and warrant.

Industry Context

Directors purchasing company stock can be seen as a positive signal, indicating confidence in the company's prospects. Convertible notes and warrants are common financing tools for companies, especially smaller ones, allowing them to raise capital.

Comparison to Industry Standards

• Convertible notes are frequently used by small-cap companies like Jaguar Health to raise capital, often with conversion prices set at a premium or discount to the current market price.
• Warrants are a common sweetener in such deals, providing additional incentive for investors.
• The specific terms (interest rate, conversion price, warrant coverage) would need to be compared to similar transactions by comparable companies to assess their favorability.

Stakeholder Impact

• Existing shareholders may experience dilution if the convertible note is converted and the warrants are exercised.
• The company gains access to capital through the issuance of the note and warrant.

Key Dates

Keywords

Jaguar Health, John Micek, convertible note, warrant, common stock, director, acquisition, securities